Baupost Group as of March 31, 2018
Portfolio Holdings for Baupost Group
Baupost Group holds 33 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cheniere Energy (LNG) | 10.7 | $1.1B | 21M | 53.45 | |
| Synchrony Financial (SYF) | 9.5 | $982M | 29M | 33.53 | |
| Twenty-first Century Fox | 9.4 | $976M | 27M | 36.69 | |
| ViaSat (VSAT) | 8.7 | $898M | 14M | 65.72 | |
| Allergan | 7.7 | $799M | 4.8M | 168.29 | |
| Qorvo (QRVO) | 7.5 | $775M | 11M | 70.45 | |
| Time Warner | 7.4 | $766M | 8.1M | 94.58 | |
| Pioneer Natural Resources | 6.6 | $687M | 4.0M | 171.78 | |
| Antero Res (AR) | 5.1 | $528M | 27M | 19.85 | |
| Fox News | 4.0 | $416M | 11M | 36.37 | |
| Cardinal Health (CAH) | 3.1 | $320M | 5.1M | 62.68 | |
| Colony Northstar | 2.7 | $279M | 50M | 5.62 | |
| Pbf Energy Inc cl a (PBF) | 2.6 | $269M | 7.9M | 33.90 | |
| Atara Biotherapeutics | 2.4 | $244M | 6.3M | 39.00 | |
| McKesson Corporation (MCK) | 2.2 | $228M | 1.6M | 140.87 | |
| Theravance Biopharma (TBPH) | 2.2 | $226M | 9.3M | 24.25 | |
| Veritiv Corp - When Issued | 1.4 | $150M | 3.8M | 39.20 | |
| PG&E Corporation (PCG) | 1.3 | $138M | 3.1M | 43.93 | |
| AmerisourceBergen (COR) | 1.1 | $114M | 1.3M | 86.21 | |
| Keryx Biopharmaceuticals | 1.0 | $106M | 26M | 4.09 | |
| Amc Entmt Hldgs Inc Cl A | 0.7 | $70M | 5.0M | 14.05 | |
| Novagold Resources Inc Cad (NG) | 0.6 | $58M | 14M | 4.33 | |
| Tesla Inc convertible security | 0.5 | $52M | 50M | 1.04 | |
| Gty Technology Holdings Inc. unit 99/99/9999 | 0.4 | $46M | 4.4M | 10.35 | |
| Paratek Pharmaceuticals | 0.3 | $31M | 2.4M | 13.00 | |
| Theravance Biopharma Inc note 3.250%11/0 | 0.3 | $30M | 30M | 1.01 | |
| Saban Cap Acquisition | 0.2 | $23M | 2.3M | 9.94 | |
| Sentinel Energy Svcs Inc unit 11/02/2022 | 0.1 | $16M | 1.6M | 9.92 | |
| Chipmos Technologies | 0.1 | $15M | 934k | 15.85 | |
| Trilogy Metals (TMQ) | 0.1 | $13M | 11M | 1.26 | |
| Forward Pharma A/s | 0.1 | $6.2M | 2.8M | 2.17 | |
| Saban Cap Acquisition Corp *w exp 09/21/202 | 0.0 | $1.5M | 1.2M | 1.30 | |
| Orexigen Therapeutics | 0.0 | $468k | 2.2M | 0.21 |
